Point pressure sensitivity in early stage Parkinson's disease

Area of Science:

• Neurology
• Sensory Neuroscience
• Parkinson's Disease Research

Background:

• Early Parkinson's disease (PD) involves sensory changes, sometimes preceding motor symptoms.
• Point pressure sensitivity (PPS), a measure of light touch via Aβ fibers, has unclear alterations in early PD.
• Previous studies are contradictory, using methods that conflate sensitivity with response criteria.

Purpose of the Study:

• To determine if point pressure sensitivity (PPS) is altered in early Parkinson's disease (PD).
• To investigate the influence of dopamine-related medications (DRMs) on PPS in PD patients.
• To correlate PPS with disease severity and dopaminergic transporter imaging.

Main Methods:

• Utilized a forced-choice staircase threshold test to measure PPS at 11 body sites.
• Compared 29 early PD patients with 29 matched controls.
• Tested patients both on and off dopamine-related medications (DRMs).

Main Results:

• Point pressure sensitivity (PPS) was not significantly influenced by early Parkinson's disease (PD).
• PPS thresholds did not correlate with medication dosage, disease rating scales, or striatal dopamine transporter levels.
• PPS thresholds showed lateralization (left vs. right) and regional differences (upper extremities vs. feet).

Conclusions:

• Point pressure sensitivity (PPS) is not affected in the early stages of Parkinson's disease (PD).
• Medication status (on or off DRMs) did not alter PPS findings in early PD patients.
• While overall PPS is preserved, regional and lateralized differences exist, warranting further investigation.